Ekansh Mittal

Dear Readers, Anil Ambani is on de-listing spree, first it was Reliance Broadcast Network (RBN) and now Reliance Mediaworks. Though it’s difficult to make money in ADAG stocks, however the way RBN’s delisting panned out (RBN was recommended to Alpha + members @ 52 in Oct’13 with successful exit @ 66), it’s like betting on fixed matches. Recently RBN successfully concluded its reverse book building and the promoters of the company (also the promoters of Reliance Mediaworks) have offered Rs 70/- per…

Dear Readers, In this post we would like to discuss a very small cap stock Caplin Point Laboratories (BSE Code – 524742). As mentioned in one of our previous posts, small and micro cap stocks are fraught with risks, however quick decision making and keeping a strong tab on the performance of such companies can also result in substantial gains. Caplin Point – Basic details Caplin Point is a debt free company with a market cap of 215 crores. The company’s…

Feb’14 Alpha stock – A good Pharma company with great valuations Dear Readers, On 25th Feb’14 we released long/medium term investment recommendation for our Alpha and Alpha + members and would like to share with you details on the same especially if you like our research and our focus on high quality companies run by good management. Our last recommendation from Pharmaceutical Industry was IPCA Laboratories in Nov’12 at Rs 445 and the stock has appreciated by 100% since then to current…

Dear Readers, CARE Rating (NSE Code – CARERATING) was recommended to Alpha and Alpha plus members in Aug’13 when the stock was around 525. The detailed report on the same was also made public on 16th Nov’13 when the stock was around 700 (CMP – 850). In case you have invested in CARE, here’s an important update regarding the latest developments in the company. The Company recently informed exchanges that its principal shareholders, IDBI, along with four other shareholders, who hold…